Barentz names Martin Thomsen its new chair of Supervisory Board

NETHERLANDS – Barentz,  a leading global speciality ingredients solution provider, has appointed, has appointed Martin Thomsen as the new chair of its Supervisory Board.

Thomsen succeeds Jürgen Steinemann, who will continue as a member of the Supervisory Board, ensuring continuity and support for the company’s ambitious goals

Thomsen brings extensive international leadership experience and expertise in transforming and scaling businesses.

Thomsen is expected to lead Barentz’s Supervisory Board by providing strategic guidance and leveraging his extensive experience in transforming and scaling businesses. 

His role involves supporting the management team in driving long-term value, strengthening the company’s position as a global leader in speciality chemical distribution, and ensuring the company’s growth aligns with its ambitious goals.

Derk Jan Terhorst, CEO of Barentz, stated, “We are delighted to welcome Martin as our new chair.” 

“His deep industry knowledge, strategic insight, and global perspective will be instrumental as we continue our growth journey and further strengthen our position as a global leader in speciality chemical distribution.”

Previously, Martin Thomsen has held key leadership roles in prominent international companies, including serving as Regional CEO and Group Chief Operating Officer at ISS, and most recently, as Group CEO of Rubix.

Recently, Barentz appointed Amanda Andrews as the new Business Development Manager – HI&I for the North America team.

According to the company, Amanda will be closely collaborating with Barentz’s cross-functional teams and principal partners to expand the business and enhance its capacity to deliver greater value to customers.

With over two decades of experience in the performance materials industry, Amanda Andrews has held key positions at leading production and distribution firms.

Her expertise in formulation, raw material development, project management, and product line expansion strengthens Barentz’s team, enhancing its ability to foster cross-functional collaborations.

In a similar move, Clariant, a Swiss speciality chemicals company, recently announced a transition in its Chief Financial Officer (CFO) position. 

Oliver Rittgen, who previously held senior roles at Bayer AG, will take over as CFO starting August 1, 2025, succeeding Bill Collins, who is retiring after serving since 2022. Rittgen brings extensive expertise in corporate finance, accounting, and risk management, having led Bayer’s Crop Science and Consumer Health divisions. 

This transition comes as Clariant continues to focus on growth and profitability, with recent first-quarter results showing improved margins and strong performance in sectors like Care Chemicals and Adsorbents.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.